{"groups":[{"description":"Cycle 1: Ixazomib: 4mg/day 1, 8, 15, Cyclophosphamide: 50 mg/day continuous daily, Dexamethasone: 20 mg/day 1, 8, 15 Cycles 2-6: Ixazomib: 4mg/day 1, 4, 8, 11, 15, 18, Cyclophosphamide: 50 mg/day continuous, daily, Dexamethasone: 20 mg/day 1, 4, 8, 11, 15, 18\n\nMaintenance:\n\nIxazomib at 4 mg days 1, 8 and 15 of a 28 day cycle for 1 ½ years\n\nIxazomib: Cycle 1:\n\nIxazomib: 4mg/day 1, 8, 15\n\nCycles 2-6:\n\nIxazomib: 4mg/day 1, 4, 8, 11, 15, 18,\n\nMaintenance:\n\nIxazomib at 4 mg days 1, 8 and 15 of a 28 day cycle for 1 ½ years\n\nCyclophosphamide: Cycle 1:\n\nCyclophosphamide: 50 mg/day continuous daily\n\nCycles 2-6:\n\nCyclophosphamide: 50 mg/day continuous daily\n\nDexamethasone: Cycle 1:\n\nDexamethasone: 20 mg/day 1, 8, 15\n\nCycles 2-6:\n\nDexamethasone: 20 mg/day 1, 4, 8, 11, 15, 18","id":"FG000","title":"Ixazomib Regimen"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"12"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"12"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}